These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 1662057)

  • 1. Experimental vaccine protection against feline immunodeficiency virus.
    Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism(s) of FIV vaccine protection.
    Pu R; Tellier MC; Yamamoto JK
    Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
    Aranyos AM; Roff SR; Pu R; Owen JL; Coleman JK; Yamamoto JK
    Vaccine; 2016 Mar; 34(12):1480-8. PubMed ID: 26802606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
    Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
    Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
    Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
    Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
    J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement after feline immunodeficiency virus vaccination.
    Hosie MJ; Osborne R; Reid G; Neil JC; Jarrett O
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):191-7. PubMed ID: 1337397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
    Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
    J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates.
    Pu R; Coleman J; Omori M; Arai M; Hohdatsu T; Huang C; Tanabe T; Yamamoto JK
    AIDS; 2001 Jul; 15(10):1225-37. PubMed ID: 11426067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
    Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
    J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the cat: development of vaccines against lentiviruses.
    Dunham SP
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive antibody protection of cats against feline immunodeficiency virus infection.
    Hohdatsu T; Pu R; Torres BA; Trujillo S; Gardner MB; Yamamoto JK
    J Virol; 1993 Apr; 67(4):2344-8. PubMed ID: 8383246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection.
    Coleman JK; Pu R; Martin M; Sato E; Yamamoto JK
    AIDS; 2005 Sep; 19(14):1457-66. PubMed ID: 16135898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
    Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
    Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against feline immunodeficiency virus using fixed infected cells.
    Verschoor EJ; van Vliet AL; Egberink HF; Hesselink W; van Alphen WE; Joosten I; Boog CJ; Horzinek MC; de Ronde A
    Vet Immunol Immunopathol; 1995 May; 46(1-2):139-49. PubMed ID: 7618254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.